Good Sense Nasal Decongestant PE Phenylephrine Hydrochloride 10 mg Tablet, 36-count
by L. Perrigo Company · 36 BLISTER PACK in 1 CARTON (0113-0094-68) / 1 TABLET in 1 BLISTER PACK
NDC 00113-0094-68
🏷️ FDA NDC (as labeled)
0113-0094-68
billing pads the labeler segment with a zero
This package
OTC
Discontinued
Non-controlled
⚠ Discontinued by firm
🗂️ Data synced Mar 13, 2024 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Excluded from the active FDA NDC Directory.
The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. The listing was last certified through Dec 2024. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory.
Search the FDA NDC Directory ↗
🆔 Identity & classification
FDA NDC (as labeled)
0113-0094-68
Product NDC
0113-0094
11-digit billing NDC
00113009468
NCPDP billing unit
EA — each (per item)
Application #
part341
Established class (EPC)
Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH FINAL
Marketing status
Discontinued
FDA listing status
Discontinued by firm (certified through Dec 2024)
Route
ORAL
Dosage form
TABLET
Substance
PHENYLEPHRINE HYDROCHLORIDE
GCN Seq No
058496
GCN
23944
HICL code
002087
Ingredient (HICL)
Phenylephrine Hcl
HIC1 code
B
Therapeutic class — broad (HIC1)
Respiratory System
HIC2 code
B6
Therapeutic class — intermediate (HIC2)
Drugs Affecting The Trachea And Bronchi (Cont3)
HIC3 code
B6V
Therapeutic class — specific (HIC3)
Decongestants, Oral
AHFS code
12:12.04.00
AHFS class
Alpha-Adrenergic Agonists (12:12)
FDB label name
GS NASAL DECONG PE 10 MG TAB
FDB brand name
Nasal Decongestant Pe
Legend status
O — Over-the-counter (OTC) drug or device
Why two NDCs?
The FDA registers this code as 0113-0094-68 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00113-0094-68. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏭 Manufacturer & labeler
LabelerL. Perrigo Company
FDA applicationpart341 (OTC MONOGRAPH FINAL)
Labeler code00113
Product typeHuman Otc Drug
Portfolio228 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
Label name GS NASAL DECONG PE 10 MG TAB Ingredient Phenylephrine Hcl
📖 What it is MedlinePlus · NLM
Phenylephrine is used to relieve nasal discomfort caused by colds, allergies, and hay fever. It is also used to relieve sinus congestion and pressure. Phenylephrine will relieve symptoms but will not treat the cause of the symptoms or speed recovery. Phenylephrine is in a class of medications called nasal decongestants. It works by reducing swelling of the blood vessels in the nasal passages.
Read the full MedlinePlus article ↗📗 Our plain-language guide HelloPharmacist
- Yes, it's the same active ingredient, but used in very different ways depending on the form. The nasal spray delivers a tiny amount directly to the nasal lining to temporarily shri...
- I see phenylephrine in nasal sprays at the pharmacy AND as an IV drug in the hospital — is it really the same medication?
- You should check with your doctor first. Phenylephrine constricts blood vessels, which can raise blood pressure and put extra strain on the heart — even from a nasal spray. If you...
- Can I use the nasal spray if I have high blood pressure or heart disease?
Patient education
Supplement & herbal interactions
Some supplements/herbs that may interact with Phenylephrine Hydrochloride — tap one for details:
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about Phenylephrine Hydrochloride?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
We could not link this NDC to a current FDA Structured Product Label. An inactive-ingredient list is therefore not available from this source.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per ea | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | $0.051 | $1.83 / 36 tablet |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
NADAC price history (per ea) — tap or hover for the price & month
▲ Up 10% over the last 15 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Nasal Decongestant PE Maximum Strength 10 mg 70677-1152-01 | Strategic | 18 tablets | $0.050 | — | Availability likely | save 2% |
| Good Sense Nasal Decongestant PE 10 mgthis 00113-0094-68 | L. | 36 tablets | $0.051 | — | Discontinued | — |
| Nasal Decongestant PE 10 mg 00363-4531-07 | Walgreen | 18 tablets | — | — | FDA listed | — |
| PhysiciansCare Sinus Non-Drowsy 10 mg 00924-0133-01 | Acme | 1 tablet | — | — | FDA listed | — |
| Sinus Pressure and Congestion Relief PE Maximum Strength 10 mg 11822-4530-02 | Rite | 24 tablets | — | — | FDA listed | — |
| Nasal Decongestant PE 10 mg 21130-0453-07 | Better | 18 tablets | — | — | FDA listed | — |
| Sinus Decongestion PE 10 mg 30142-0534-07 | Kroger | 18 tablets | — | — | FDA listed | — |
| Sinus Congestion 10 mg 30142-0853-07 | Kroger | 18 tablets | — | — | FDA listed | — |
| PE Sinus Congestion 10 mg 36800-0704-07 | Topco | 18 tablets | — | — | FDA listed | — |
| Nasal Decongestant PE 10 mg 37808-0453-23 | H | 24 tablets | — | — | FDA listed | — |
| Nasal Decongestant PE 10 mg 37835-0651-01 | Bi-Mart | 100 tablets | — | — | FDA listed | — |
| Medi-First Sinus Decongestant 10 mg 47682-0809-13 | Unifirst | 1 tablet | — | — | FDA listed | — |
| Medi-First Plus Sinus Decongestant 10 mg 47682-0990-33 | Unifirst | 1 tablet | — | — | FDA listed | — |
| Unishield Sinus Decongestant 10 mg 49314-2083-03 | Unishield | 1 tablet | — | — | FDA listed | — |
| Pseudo Time Pe 10 mg 49483-0234-00 | TIME | 100000 tablets | — | — | FDA listed | — |
| Good Sense Nasal Decongestant PE 10 mg 50090-3659-00 | A-S | 36 tablets | — | — | FDA listed | — |
| Phenylephrine HCl Maximum Strength 10 mg 50090-5606-00 | A-S | 18 tablets | — | — | FDA listed | — |
| Nasal Decongestant Pe 10 mg 50090-7449-00 | A-S | 18 tablets | — | — | FDA listed | — |
| Sudafed PE Sinus Congestion 10 mg 50580-0437-01 | Kenvue | 18 tablets | — | — | FDA listed | — |
| Sinus Congestion 10 mg 50844-0493-08 | L.N.K. | 24 tablets | — | — | FDA listed | — |
| Suphedrine PE Sinus Congestion Non-Drowsy 10 mg 55301-0753-23 | ARMY | 24 tablets | — | — | FDA listed | — |
| SU PHEDRINE PE Non-Drowsy, Maximum Strength 10 mg 57243-0453-44 | Salado | 18 tablets | — | — | FDA listed | — |
| Su Phedrine Pe Sinus Congestion 10 mg 57243-0953-44 | Salado | 18 tablets | — | — | FDA listed | — |
| Phenylephrine Hydrochloride 10 mg 57631-0018-00 | InvaTech | 30000 tablets | — | — | FDA listed | — |
| Nasal Decongestant PE Non-Drowsy Maximum Strength 10 mg 63868-0144-19 | CHAIN | 18 tablets | — | — | FDA listed | — |
| Nasal Decongestant PE Maximum Strength 10 mg 67091-0207-18 | WinCo | 18 tablets | — | — | FDA listed | — |
| Nasal Decongestant PE Maximum Strength Non-Drowsy 10 mg 69168-0272-17 | Allegiant | 300 tablets | — | — | FDA listed | — |
| Redicare Nasal and Sinus Decongestant 10 mg 71105-0272-02 | Redicare | 100 tablets | — | — | FDA listed | — |
| Gencare-Nasal Decongestant PE 10 mg 72090-0025-01 | Pioneer | 300 tablets | — | — | FDA listed | — |
| Gencare-Nasal Decongestant PE 10 mg 72090-0039-01 | Pioneer | 300 tablets | — | — | FDA listed | — |
| Crane Safety Sinus Decongestant 10 mg 73408-0990-33 | Crane | 1 tablet | — | — | FDA listed | — |
| ValuMeds Nasal Decongestant Phenylephrine HCl 10 mg 82725-1111-01 | Cabinet | 300 tablets | — | — | FDA listed | — |
| Goodmeds Non-Drowsy Nasal Decongestant PE 10 mg 82725-4111-01 | Cabinet | 365 tablets | — | — | FDA listed | — |
| Sinus Congestion 10 mg 83324-0073-18 | Chain | 18 tablets | — | — | FDA listed | — |
| Phenylephrine Hydrochloride 10 mg 83586-0010-00 | HHH | 130000 tablets | — | — | FDA listed | — |
| Nasal Decongestant PE 10 mg 83586-0160-01 | HHH | 100 tablets | — | — | FDA listed | — |
| Nasal Decongestant PE 10 mg 84324-0010-01 | NUVICARE | 100 tablets | — | — | FDA listed | — |
| Nasal Decongestant PE Maximum Strength 10 mg 85766-0178-18 | Sportpharm | 18 tablets | — | — | FDA listed | — |
| Medi-First Plus Sinus Decongestant 10 mg 85766-0182-01 | Sportpharm | 1 tablet | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
📍
2026
Currently FDA-listed
listed with the FDA
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Phenylephrine Hydrochloride — the ingredient across all brands.
Top reported reactions
Age at onset
Reporter sex
Male · 31%
Female · 69%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Per unit | Per pack | Marketing start | Status |
|---|---|---|---|---|---|
| 00113-0094-23 | 72 BLISTER PACK in 1 CARTON (0113-0094-23) / 1 TABLET in 1 BLISTER PACK | $0.0508 / ea | $3.66 | 2005-06-28 | Discontinued by firm |
| 00113-0094-68 You're viewing this | 36 BLISTER PACK in 1 CARTON (0113-0094-68) / 1 TABLET in 1 BLISTER PACK | $0.0508 / ea | $1.83 | 2005-08-01 | Discontinued by firm |
| 00113-0094-89 | 18 BLISTER PACK in 1 CARTON (0113-0094-89) / 1 TABLET in 1 BLISTER PACK | $0.0508 / ea | $0.91 | 2005-06-21 | Discontinued by firm |
This pack effectively ties for the lowest per-ea cost of the 3 priced pack sizes ($0.0508 NADAC).
Pack size FAQ
What quantity is in NDC 00113-0094-68?
NDC 00113-0094-68 is a 36-count package — 36 blister pack in 1 carton / 1 tablet in 1 blister pack.
What is the difference between NDC 00113-0094-68 and NDC 00113-0094-89?
Both are Good Sense Nasal Decongestant PE Phenylephrine Hydrochloride 10 mg Tablet — the drug itself is identical. NDC 00113-0094-68 is the 36-count package, while NDC 00113-0094-89 is the 18 tablets package.
What NDC number is used to bill for this package of Good Sense Nasal Decongestant PE Phenylephrine Hydrochloride 10 mg Tablet?
Bill NDC 00113-0094-68 — the 11-digit billing format is 00113009468. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.
🧭 About this NDC listing & data coverage
Over-the-counter (OTC) product
No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | — Not published for this NDC No structured label is linked to this listing in DailyMed/openFDA. |
| Package photos | — Not published for this NDC The FDA label for this product carries no photos. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | ✓ Available |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Final". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no full label on this page?
No structured FDA label (SPL) is currently linked to this NDC in DailyMed/openFDA. That can happen with older listings, certain OTC and repackaged products, and recently updated listings whose label has not yet propagated. The listing itself is still valid — this page shows everything the public feeds provide for this package.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 0113-0094-68, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 00113-0094-68, written without dashes as 00113009468. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 00113-0094-68, the first segment (00113) is the labeler code FDA assigned to L. Perrigo Company; the middle segment (0094) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (68) identifies this exact package size and type. Together they name one specific package of one specific product.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 18 tablets (00113-0094-89), 72 tablets (00113-0094-23). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
L. Perrigo Company is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.